Home Amgen, Cytokinetics Heart Failure Drug Succeeds In Mid-Stage Study
 

Keywords :   


Amgen, Cytokinetics Heart Failure Drug Succeeds In Mid-Stage Study

2015-10-28 08:39:05| Biotech - Topix.net

Amgen Inc and Cytokinetics Inc said on Tuesday their experimental drug for chronic heart failure showed significant improvement in cardiac function in the second part of a mid-stage study. The 448 patients in the trial were given an oral formulation of the drug omecamtiv mecarbil for 20 weeks and observed for 24 weeks, the companies said in a joint statement.

Tags: study heart drug failure

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
27.11topps now psa10
27.11 THE ORAL CIGARETTES SUCK MY WORLD
27.11 E
27.113DS .SD()
27.11181
27.11YAMAHA KUSHITANI LL
27.11tsnomi.com
27.11
More »